Anti-Human NTRK1 Monoclonal Antibody (1A717) from ProteoGenix; catalogue ARO-A23475; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Human NTRK1 Monoclonal Antibody (1A717) is a highly specific and potent tool for studying the biological function of NTRK1, also known as TrkA. This antibody is produced using advanced monoclonal antibody technology and has been extensively validated for use in a variety of applications.
NTRK1 is a receptor tyrosine kinase that plays a crucial role in cell growth, differentiation, and survival. It is a key regulator of the nervous system and is involved in various diseases, including cancer. This makes NTRK1 an important target for research and drug development.
The main applications of the Anti-Human NTRK1 Monoclonal Antibody (1A717) include Western blotting, immunohistochemistry, and flow cytometry. It has been shown to specifically recognize NTRK1 in human tissues and cell lines, making it a reliable tool for studying the expression and localization of this protein.
In addition to its use in basic research, this antibody has also been used in experimental studies to investigate the role of NTRK1 in various diseases. For example, it has been used to study the role of NTRK1 in breast cancer and its potential as a therapeutic target.
With its high specificity and sensitivity, the Anti-Human NTRK1 Monoclonal Antibody (1A717) is a valuable tool for researchers studying NTRK1 and its role in various biological processes and diseases. Its use in multiple applications and experimental studies highlights its versatility and reliability.
In summary, the Anti-Human NTRK1 Monoclonal Antibody (1A717) is a powerful tool for studying the function of NTRK1 and its potential as a therapeutic target in various diseases. Its specificity, sensitivity, and versatility make it a top choice for researchers in the biotech field. Order now and advance your research with this highly effective antibody.
ProteoGenix catalogue number ARO-A23475. For research use only.
Target: High affinity nerve growth factor receptor, EC:2.7.10.1, Neurotrophic tyrosine kinase receptor type 1, TRK1-transforming tyrosine kinase protein, Tropomyosin-related kinase A, Tyrosine kinase receptor, Tyrosine kinase receptor A, Trk-A, gp140trk, p140-TrkA, NTRK1; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
